发布: 2014年05月05日第4卷第9期 DOI: 10.21769/BioProtoc.1114 浏览次数: 8329
Abstract
Vaccine-based immunotherapy is being used to treat dogs with primary brain tumors. The vaccines are composed of a lysate of autologous tumor cells, which stimulate an immune response producing tumor specific antibodies that are capable of inducing antibody-dependent cell-mediated cytotoxicity to allogeneic, as well as autologous, tumor cells. This protocol will describe the tumor cell serum antibody-binding assay to measure the tumor-reactive IgG antibody response. Key features of this assay are that it is performed with sera collected from the canine patient prior to and following vaccination as the source of antibodies and canine brain tumor cells used as the target cells.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2014 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Andersen, B. M., Goulart, M. R., Olin, M. R. and Pluhar, G. E. (2014). Detection of Tumor Cell Surface-reactive Antibodies. Bio-protocol 4(9): e1114. DOI: 10.21769/BioProtoc.1114.
分类
癌症生物学 > 肿瘤免疫学 > 免疫学试验
癌症生物学 > 通用技术 > 生物化学试验
免疫学 > 抗体分析 > 抗体功能
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link